Discover
PRCT
PROCEPT BioRobotics Corporation
18.52
1 x 18.21
1 x 18.94
bid
ask
+
0.00
0.00%
10 @ 08:48 AM
18.59 +0.07 (0.38%)
| Ytd | -41.13% | |
| 1y | -67.54% |
day range
17.96
52 week range
60.57
| Open | Prev Close | 18.52 | Low | High | Mkt Cap | 1.05B | |||
| Vol | 0.00 | Avg Vol | 1.62M | EPS | -1.82 | P/E | -10.18 | Forward P/E | -22.56 |
| Beta | 0.87 | Short Ratio | 5.45 | Inst. Own | 102.44% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 24.04 | 200-d Avg | 28.21 | 1yr Est | 29.30 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2026-08-04 | 2026-06 | -0.46 | N/A | N/A | N/A |
| 2026-04-29 | 2026-03 | -0.55 | -0.56 | -0.01 | -1.82% |
| 2026-02-25 | 2025-12 | -0.32 | -0.53 | -0.21 | -65.62% |
| 2025-11-04 | 2025-09 | -0.41 | -0.38 | 0.03 | 7.32% |
| 2025-08-06 | 2025-06 | -0.41 | -0.35 | 0.06 | 14.63% |
| 2025-04-24 | 2025-03 | -0.49 | -0.45 | 0.04 | 8.16% |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2026-07-06 | Truist Securities | Downgrade | Buy | Hold |
| 2026-06-24 | Evercore ISI Group | Upgrade | Outperform | |
| 2026-06-11 | Leerink Partners | Downgrade | Outperform | Market Perform |
| 2026-04-30 | Piper Sandler | Upgrade | Overweight | Overweight |
| 2026-03-06 | Baird | Upgrade | Neutral | |
| 2026-03-02 | Truist Securities | Upgrade | Buy | Buy |
Profile
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2026-06-08 | DESAI ANTAL ROHIT | Director | 38.47K | Stock Award(Grant) |
| 2026-06-08 | GARRETT MARY | Director | 17.70K | Stock Award(Grant) |
| 2026-06-08 | HARRIS TAYLOR C | Director | 102.49K | Stock Award(Grant) |
| 2026-06-08 | MOLL FREDERIC H | Director | 866.47K | Stock Award(Grant) |
| 2026-06-07 | NOURI ALALEH | Officer | 105.07K | Sale |
| 2025-06-05 | SHIBLAQ HISHAM | Officer | 63.13K | Sale |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2025-12-30 | Vanguard Group Inc | 5.20M | 0.00 | 9.14% |
| 2026-03-30 | BlackRock Inc | 4.36M | 0.00 | 7.66% |
| 2026-03-30 | T. Rowe Price Investment Management,Inc. | 3.27M | 0.00 | 5.75% |
| 2026-03-30 | BNP Paribas Investment Partners SA | 3.09M | 0.00 | 5.43% |
| 2026-03-30 | Vanguard Portfolio Management, LLC | 2.42M | 0.00 | 4.25% |
| 2026-03-30 | Vanguard Capital Management, LLC | 2.40M | 0.00 | 4.21% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2026-06-29 | Vanguard Total Stock Mkt Idx Inv | 1.71M | 0.00 | 3.00% |
| 2026-06-29 | iShares Russell 2000 ETF | 1.47M | 0.00 | 2.58% |
| 2026-03-30 | T. Rowe Price US Small-Cap Core Equity | 1.32M | 0.00 | 2.32% |
| 2026-06-29 | T. Rowe Price Small-Cap Stock | 1.32M | 0.00 | 2.32% |
| 2026-04-29 | Canada Life US Small-Mid Cap Growth F | 1.25M | 0.00 | 2.20% |
| 2026-06-29 | Vanguard Small Cap Index | 1.24M | 0.00 | 2.18% |